Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Clinical briefs for Thursday, Nov. 16
By
Kristen Fischer
Nov 16, 2023
Study links military service with Alzheimer’s disease … Drug could “switch” memory protein in brain …Gene therapy for osteoarthritis looks good in trial … Nurses still need better support,...
Popular TV series may help reduce stigma around Alzheimer’s
By
John Roszkowski
Sep 02, 2022
The narrative and dramatization of Alzheimer’s disease in the popular TV series “This is Us” may help reduce the stigma around dementia and promote family discussions about plans for aging, new...
Vigorous exercise may guard against death from Alzheimer’s disease
By
Kristen Fischer
Dec 18, 2023
Engaging in vigorous activity compared to moderate exercise may lower the rate of dying from Alzheimer’s disease, according to a new study. The study was published in the December issue of The Lancet...
Mid-life racial discrimination in Black Americans tied to Alzheimer’s later on, study finds
By
Kristen Fischer
Apr 12, 2024
Racial discrimination during midlife is linked to Alzheimer’s disease, a new study finds.
Older adults who volunteered more often had better emotional well-being, were less likely to have Alzheimer’s disease and had lower risks for not being able to perform activities of daily living.
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
Medicare costs could rise by $5B annually with expanded Alzheimer’s drug coverage: study
By
Alicia Lasek
May 12, 2023
Medicare costs could rise by $2 to $5 billion a year if CMS expands its coverage for newly approved Alzheimer’s disease drug Leqembi (lecanemab), investigators say.
Scent waning? This Alzheimer’s gene may be the culprit, study shows
By
Kristen Fischer
Jul 27, 2023
Sense of smell may be the first to go in people who carry a gene variant that’s linked to the highest risk for Alzheimer’s disease, according to a new study.
Hurricanes hastened the deaths of adults with dementia, study finds
By
Alicia Lasek
Mar 08, 2023
People with Alzheimer’s and related dementias (ADRD) had higher mortality rates in U.S. counties that had recently experienced a hurricane disaster, investigators report.